Wilms' tumor and preferentially expressed antigen of melanoma in patients with myeloid neoplasms treated with azacytidine
Sign Up to like & getrecommendations! Published in 2019 at "European Journal of Haematology"
DOI: 10.1111/ejh.13312
Abstract: In their recent paper, Santaliestra et al measured bone marrow (BM) Wilms' tumor (WT1) mRNA levels in patients with myeloid neoplasms treated with 5-azacytidine (5-AZA)1 . Patients with initial WT1 levels greater than 100 copies but… read more here.
Keywords: myeloid neoplasms; tumor preferentially; neoplasms treated; treated azacytidine ... See more keywords